fda authorizes lung cancer imaging agent based on research from purdue
Published 1 year ago • 74 plays • Length 40:04Download video MP4
Download video MP3
Similar videos
-
41:40
full video interview with purdue professor philip low on pioneering drug for ovarian cancer surgery
-
3:25
purdue expert: lung cancer detection drug
-
4:30
fda approves new ovarian cancer detection drug by purdue researcher
-
5:59
fda approves ‘illuminating’ drug for spotting cancer
-
1:04
fda approved purdue lung cancer drug
-
2:29
purdue expert: cancer imaging drug
-
1:58
fda approves the first cancer drug targeting a tumor solely based on its dna | nbc nightly news
-
2:19
fda approval to targeted imaging agent pafolacianine for use in lung cancer surgery
-
0:46
fda approves capmatinib for advanced lung cancer
-
4:21
renowned purdue researcher earns another fda approval
-
2:16
fda approves purdue developed drug for ovarian cancer surgery
-
0:46
fda approves new drug to treat lung cancer
-
2:43
fda approves durvalumab / imfinzi for resectable nsclc non-small cell lung cancer
-
0:36
dr. camidge on the fda approval of pembrolizumab for squamous nsclc
-
23:15
purdue institute for cancer research raises $100,000 in annual challenge 5k
-
1:37
purdue technology used in first fluorescence-guided cancer surgery
-
6:01
fda d.i.s.c.o.: osimertinib for non-small cell lung cancer
-
9:00
fda d.i.s.c.o.: two approvals for alk-positive non-small cell lung cancer
-
8:31
fda d.i.s.c.o.: first biosimilar approval for the treatment of cancer